David J. Millar

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

Karl Bodin, Stéphan Ellmerich, Melvyn Kahan et al. · Nature · 2010 · 338 citations · Full text

Pharmacy, Biochemistry, Pathology +10

Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis

Julian D. Gillmore, Glenys A. Tennent, Winston L. Hutchinson et al. · British Journal of Haematology · 2010 · 138 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Pathogenetic mechanisms of amyloid A amyloidosis

J. Paul Simons, Raya Al‐Shawi, Stéphan Ellmerich et al. · Proceedings of the National Academy of Sciences · 2013 · 120 citations · Full text

Medicine, Pathobiology, Pharmacology +17

The Landscape Evolution Observatory: A large-scale controllable infrastructure to study coupled Earth-surface processes

Luke Pangle, Stephen B. DeLong, John Adams et al. · Geomorphology · 2015 · 57 citations

Natural Sciences, Earth Sciences, Meteorology +12

Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use

Mark B. Pepys, J. Ruth Gallimore, Joanne Lloyd et al. · Journal of Immunological Methods · 2012 · 36 citations · Full text

Life Sciences, Immunology, Pharmacology +6